jRCT2031220627已完成不适用
A Single Dose Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics of MK-2214 in Healthy Japanese Participants
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- MSD K.K.
- 入组人数
- 48
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized Controlled Trial
- 干预模型
- Parallel Assignment
- 主要目的
- Other
- 盲法
- Double Blind
入排标准
- 年龄范围
- 18age old over 至 75age old under（—）
- 性别
- All
入选标准
- •Healthy male or female aged 18 to 75 years old with BMI 18 to 30 kg/m2
排除标准
- •Has a history of clinically significant abnormalities or diseases
结局指标
主要结局
-
Adverse event
次要结局
未报告次要终点
研究者
相似试验
已完成
不适用
Single Dose Study of MK-2060 in Healthy Japanese ParticipantsjRCT2031220658MSD K.K.48
进行中（未招募）
不适用
Phase 1 study of MK-5684 in Japanese Participants with mCRPCjRCT2031230431MSD K.K.8
已完成
不适用
Single Dose Study of MK-2060 in Japanese Older Participants on DialysisjRCT2041230025MSD K.K.16
招募中
1 期
Phase I Study of AK1910 in Healthy Japanese Subjects, Healthy Caucasian Subjects, Patients with Systemic Lupus Erythematosus (Single Dose and Multiple Dose Study)Systemic Lupus ErythematosusJPRN-jRCT2071230085Sato Kumiko120
招募中
不适用
Phase I Study of AK1910 in Healthy Japanese Subjects, Healthy Caucasian Subjects, Patients with Systemic Lupus Erythematosus
(Single Dose and Multiple Dose Study)Systemic Lupus ErythematosusjRCT2071230085Asahi Kasei Pharma Corporation120